BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19360443)

  • 1. Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy.
    Gentile M; Galli C; Pagnotti P; Di Marco P; Tzantzoglou S; Bellomi F; Ferreri ML; Selvaggi C; Antonelli G
    Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):977-81. PubMed ID: 19360443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
    Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
    Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
    J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
    Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
    Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
    Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
    Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
    Lagrou K; Bodeus M; Van Ranst M; Goubau P
    J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.
    Daiminger A; Bäder U; Eggers M; Lazzarotto T; Enders G
    J Clin Virol; 1999 Aug; 13(3):161-71. PubMed ID: 10443792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of commercial cytomegalovirus IgG avidity diagnostic kit.
    Yang JM; Li JX; Guo ZX
    Clin Lab; 2014; 60(8):1377-82. PubMed ID: 25185425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
    Prince HE; Lapé-Nixon M; Novak-Weekley SM
    Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.
    Revello MG; Genini E; Gorini G; Klersy C; Piralla A; Gerna G
    J Clin Virol; 2010 Aug; 48(4):255-9. PubMed ID: 20561816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
    Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
    Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
    Carlier P; Harika N; Bailly R; Vranken G
    J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
    Delforge ML; Eykmans J; Steensels D; Costa E; Donner C; Montesinos I
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):208-212. PubMed ID: 30361044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
    Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
    Seo S; Cho Y; Park J
    Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection.
    Chiereghin A; Pavia C; Gabrielli L; Piccirilli G; Squarzoni D; Turello G; Gibertoni D; Simonazzi G; Capretti MG; Lanari M; Lazzarotto T
    J Virol Methods; 2017 Oct; 248():250-254. PubMed ID: 28801056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
    Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
    Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
    J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.